HOMEVULNERABILITIESCVE-2026-5163
MEDIUM

CVE-2026-5163

CWE-862Published: May 18, 2026· Updated: May 18, 2026

6.5
CVSS v3.1
EPSS:0.04%probability of exploitation in 30 daysPercentile:11.5th

Official Description

Mattermost versions 11.5.x <= 11.5.1 fail to verify channel membership when processing AI-assisted message rewrites which allows an authenticated attacker to read the content of threads in private channels and direct messages they do not have access to via a crafted request to the post rewrite endpoint.. Mattermost Advisory ID: MMSA-2026-00645

NVD Source

Technical Analysis

CVE-2026-5163 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

Exploitation requires low privileges, which limits the exposure to scenarios where an attacker has already gained initial access.

A successful exploit results in complete confidentiality breach (data exposure), with a CVSS base score of 6.5.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.Low
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityHigh
IntegrityNone
AvailabilityNone
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Affected Vendors & Products

mattermost1 product
mattermost server
Source: NVD CPE · 1 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (1)

Quick Facts

CVE IDCVE-2026-5163
CVSS Score6.5 / 10
SeverityMEDIUM
WeaknessCWE-862
CISA KEVNo
EPSS (30d)0.04%
Affected1 vendor
PublishedMay 18, 2026

Related CVEs (CWE-862)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2026-5163 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.